Latest Schedule 13G passive stakes

Several QS-affiliated entities have reported their beneficial ownership of BBB Foods Inc. Class A Common Shares, with holdings converted from Class C shares.

AuGC BioFund LP, AuGC Partners LLC, and Evan Markegard have jointly reported beneficial ownership of 4.7% of Palatin Technologies Inc. common stock.

Kynam Capital Management, LP, along with its affiliates, has reported beneficial ownership of 4.01% of Vera Therapeutics, Inc.'s Class A common stock as of June 30, 2026.

Valiant Capital Management, L.P., Valiant Capital Management, LLC, and Christopher R. Hansen have jointly filed a Schedule 13G, reporting beneficial ownership of 5.3% of Core Scientific, Inc. common stock as of June 30, 2026.

Kynam Capital Management, LP, Kynam Capital Management GP, LLC, and Yue Tang have reported beneficial ownership of 9.96% of CytomX Therapeutics' common stock as of June 30, 2026.

SilverArc Capital Management, LLC and Devesh Gandhi have reported beneficial ownership of 9.99% of Cellectar Biosciences Inc.'s Class A Common Stock, primarily through exercisable warrants.

First Trust Merger Arbitrage Fund and affiliated entities report holding zero shares of GP-Act III Acquisition Corp. Class A Ordinary Shares as of June 30, 2026.

Kynam Capital Management, LP, along with its GP and principal Yue Tang, has reported a 6.78% beneficial ownership of Celldex Therapeutics, Inc. common stock as of June 30, 2026.

Laurence W. Lytton and the Lytton-Kambara Foundation have jointly filed an update regarding their beneficial ownership of Aytu BioPharma, Inc. common stock, maintaining their holdings below the 5% threshold.

Earnest Partners, LLC has updated its Schedule 13G filing, reporting beneficial ownership of 6.0% of Sabre Corp. common stock as of June 30, 2026.

FF Hybrid, LP, along with Flat Footed LLC and Marc Andersen, has reported a beneficial ownership of 51,012,447 shares, representing 7.9% of Service Properties Trust's common stock.

Linden Capital L.P. and associated entities have filed an amendment to their Schedule 13G for Graf Global Corp., reporting 0 shares beneficially owned as of June 30, 2026.

Earnest Partners LLC has disclosed a beneficial ownership of 3,763,214 shares, representing 4.8% of the outstanding common stock of FormFactor Inc., as of June 30, 2026.

Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC have filed a Schedule 13G, disclosing beneficial ownership of Hain Celestial Group, Inc. common stock.

Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC have filed a Schedule 13G, disclosing beneficial ownership of Hain Celestial Group, Inc. common stock.

Linden Capital L.P. and affiliated entities have filed an amendment to their Schedule 13G, confirming zero beneficial ownership of Enhanced Group Inc. Class A Common Stock as of June 30, 2026.

Linden Capital L.P. and associated entities have filed an amendment to their Schedule 13G concerning Paloma Acquisition Corp I, detailing beneficial ownership as of June 30, 2026.

Earnest Partners, LLC has reported a beneficial ownership of 2,890,502 shares, representing 8.8% of the outstanding common stock of Papa John's International Inc. as of June 30, 2026.

StemPoint Capital LP, along with affiliated entities, has reported beneficial ownership of 628,866 shares, representing 9.5% of Xilio Therapeutics' common stock, primarily through warrants.

Parvus Asset Management Jersey Ltd and Edoardo Mercadante report a beneficial ownership of 15,191,321 ordinary shares in Flutter Entertainment plc, representing 8.8% of the class.

StemPoint Capital LP, along with affiliated entities, has reported beneficial ownership of 5.0% of Surrozen, Inc.'s common stock, primarily through warrant holdings.

Linden Capital L.P. and associated entities have filed an amendment to their Schedule 13G, reporting beneficial ownership of 750,000 ordinary shares in Future Money Acquisition Corporation as of June 30, 2026.

StemPoint Capital LP, StemPoint Capital Management GP LLC, and Michelle Ross have jointly filed an amendment to their Schedule 13G, reporting 0 shares beneficially owned in Faeth Therapeutics, Inc.

The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC have filed an amendment to their Schedule 13G, reporting 0.0% beneficial ownership of Four Leaf Acquisition Corporation's Class A common stock as of June 30, 2026.

The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC have filed an amendment to their Schedule 13G, reporting 0.0% beneficial ownership of Four Leaf Acquisition Corporation's Class A common stock as of June 30, 2026.

Centurion Acquisition Corp. has filed an amendment to its Schedule 13G, detailing beneficial ownership changes as of June 30, 2026.

Earnest Partners LLC has disclosed a beneficial ownership of 3,099,996 shares, representing 8.1% of the outstanding common stock of Insperity, Inc.

Several First Trust entities have jointly filed a Schedule 13G/A, reporting their beneficial ownership of Lionheart Holdings' Class A Ordinary Shares.

An investment group, including FF Hybrid, LP, Flat Footed LLC, and Marc Andersen, has increased its beneficial ownership of Diversified Healthcare Trust to 9.7%, holding 23,487,002 shares.

Bellevue Group AG and its subsidiary Bellevue Asset Management AG have reported beneficial ownership of 5.0% of Jade Biosciences, Inc. common stock.